Hypersomatotropism and Hypercortisolism Caused by a Plurihormonal Pituitary Adenoma in a Dog
A 12-year-old, male Labrador Retriever was presented because of polyuria, polydipsia, polyphagia, joint pain, and physical features consistent with acromegaly. Circulating insulin-like growth factor-1 (IGF-1) concentration was increased (> 1000 ng/mL; reference interval [RI], 42-449), suggestive of hypersomatotropism. An abnormal low-dose dexamethasone suppression test and increased circulating adrenocorticotropic (ACTH) concentration indicated pituitary-dependent hypercortisolism. Computed tomography identified an enlarged pituitary gland. Treatment with cabergoline initially decreased circulating IGF-1 and ACTH concentrations and urinary cortisol-to-creatinine ratio (UCCR), with a notable reduction in acromegalic physical features. However, 7 months after the start of cabergoline treatment, IGF-1, ACTH, and UCCR had increased again, although pituitary gland size remained stable. Because of worsening joint pain, euthanasia was performed. On necropsy, double immunohistochemistry identified pituitary tumor cells with cytoplasmic co-expression of both growth hormone (GH) and ACTH, consistent with a monomorphic plurihormonal macroadenoma. This case shows that concurrent hypersomatotropism and hypercortisolism can occur in dogs caused by a plurihormonal pituitary adenoma.
Authors
- H.S. Kooistra (ORCID: https://orcid.org/0000-0002-8058-0492)
- Elber Alberto Soler Arias (ORCID: https://orcid.org/0000-0001-6658-4748)
- Adrian Daly (ORCID: https://orcid.org/0000-0001-6130-2975)
- Ricardo Rodas Elvir
Institutions
- University of Liège (BE)
- University of Applied Sciences Utrecht (NL)
- Utrecht University (NL)
- Universidad de Buenos Aires (AR)
- Sociedad Española de Nefrología (ES)
- Centre Hospitalier Universitaire de Liège (BE)
Publication Details
- Journal
- Journal of Veterinary Internal Medicine
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1111/jvim.70177
- Citations
- 1
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.29